Central core disease: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
| Line 14: | Line 14: | ||
{{CMG}} | {{CMG}} | ||
{{SK}} Central core myopathy | |||
==Overview== | |||
'''Central core disease''' (CCD) is an [[autosomal dominant]] [[congenital myopathy]] (inborn [[skeletal muscle|muscle]] disorder). It was first described by Shy and Magee in 1956.<ref>{{cite journal |author=Magee KR, Shy GM |title=A new congenital non-progressive myopathy |journal=Brain |volume=79 |issue=4 |pages=610-21 |year=1956 |pmid=13396066 |doi=}}</ref><ref name=Quinlivan/> | '''Central core disease''' (CCD) is an [[autosomal dominant]] [[congenital myopathy]] (inborn [[skeletal muscle|muscle]] disorder). It was first described by Shy and Magee in 1956.<ref>{{cite journal |author=Magee KR, Shy GM |title=A new congenital non-progressive myopathy |journal=Brain |volume=79 |issue=4 |pages=610-21 |year=1956 |pmid=13396066 |doi=}}</ref><ref name=Quinlivan/> | ||
==Signs and symptoms== | ==Signs and symptoms== | ||
The symptoms of central core disease are variable, but usually involve [[hypotonia]] ("floppy infant") at birth, mild delay in [[child development]] (highly variable between cases), weakness of the [[Facial muscles|face muscles]], and skeletal malformations such as [[scoliosis]] and [[dislocation of hip|hip dislocation]].<ref name=Quinlivan>{{cite journal |author=Quinlivan RM, Muller CR, Davis M, ''et al'' |title=Central core disease: clinical, pathological, and genetic features |journal=Arch. Dis. Child. |volume=88 |issue=12 |pages=1051-5 |year=2003 |pmid=14670767 |url=http://adc.bmj.com/cgi/content/full/88/12/1051}}</ref> | The symptoms of central core disease are variable, but usually involve [[hypotonia]] ("floppy infant") at birth, mild delay in [[child development]] (highly variable between cases), weakness of the [[Facial muscles|face muscles]], and skeletal malformations such as [[scoliosis]] and [[dislocation of hip|hip dislocation]].<ref name=Quinlivan>{{cite journal |author=Quinlivan RM, Muller CR, Davis M, ''et al'' |title=Central core disease: clinical, pathological, and genetic features |journal=Arch. Dis. Child. |volume=88 |issue=12 |pages=1051-5 |year=2003 |pmid=14670767 |url=http://adc.bmj.com/cgi/content/full/88/12/1051}}</ref> | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis is made on the combination of typical symptoms and the appearance on [[biopsy]] (tissue sample) from muscle. The name derives from the typical appearance of the biopsy on [[light microscopy]], where the muscle cells have cores that are devoid of [[mitochondrion|mitochondria]] and specific [[enzyme]]s.<ref name=Quinlivan/> | The diagnosis is made on the combination of typical symptoms and the appearance on [[biopsy]] (tissue sample) from muscle. The name derives from the typical appearance of the biopsy on [[light microscopy]], where the muscle cells have cores that are devoid of [[mitochondrion|mitochondria]] and specific [[enzyme]]s.<ref name=Quinlivan/> | ||
| Line 33: | Line 37: | ||
==Treatment== | ==Treatment== | ||
There is no specific treatment but triggering anesthetics are avoided and relatives are screened for ''RYR1'' mutations as these may make them susceptible to MH.<ref name=Quinlivan/> | There is no specific treatment but triggering anesthetics are avoided and relatives are screened for ''RYR1'' mutations as these may make them susceptible to MH.<ref name=Quinlivan/> | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{PNS diseases of the nervous system}} | {{PNS diseases of the nervous system}} | ||
Latest revision as of 16:56, 15 August 2012
| Central core disease | |
| ICD-10 | G71.2 |
|---|---|
| ICD-9 | 359.0 |
| OMIM | 117000 |
| eMedicine | neuro/76 |
| MeSH | D020512 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Central core myopathy
Overview
Central core disease (CCD) is an autosomal dominant congenital myopathy (inborn muscle disorder). It was first described by Shy and Magee in 1956.[1][2]
Signs and symptoms
The symptoms of central core disease are variable, but usually involve hypotonia ("floppy infant") at birth, mild delay in child development (highly variable between cases), weakness of the face muscles, and skeletal malformations such as scoliosis and hip dislocation.[2]
Diagnosis
The diagnosis is made on the combination of typical symptoms and the appearance on biopsy (tissue sample) from muscle. The name derives from the typical appearance of the biopsy on light microscopy, where the muscle cells have cores that are devoid of mitochondria and specific enzymes.[2]
Respiratory insufficiency develops in a small proportion of cases. Creatine kinase and electromyography (EMG) tend to be normal.[2]
Pathophysiology
Central core disease is inherited in an autosomal dominant fashion. More than half the cases have demonstrable mutations in the ryanodine receptor type 1 (RYR1) gene, which are often de novo (newly developed). People with CCD are at risk for malignant hyperthermia (MH) when receiving general anesthesia.[2]
Treatment
There is no specific treatment but triggering anesthetics are avoided and relatives are screened for RYR1 mutations as these may make them susceptible to MH.[2]
References
- ↑ Magee KR, Shy GM (1956). "A new congenital non-progressive myopathy". Brain. 79 (4): 610–21. PMID 13396066.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Quinlivan RM, Muller CR, Davis M; et al. (2003). "Central core disease: clinical, pathological, and genetic features". Arch. Dis. Child. 88 (12): 1051–5. PMID 14670767.